Claude Fable 5: The New Frontier of Mythos-Class AI Capabilities

temp_image_1781028343.416471 Claude Fable 5: The New Frontier of Mythos-Class AI Capabilities

Experience the Next Evolution of Intelligence: Introducing Claude Fable 5

The landscape of artificial intelligence has just shifted. We are thrilled to announce the launch of Claude Fable 5, a powerhouse Mythos-class model designed to push the boundaries of what AI can achieve while maintaining a rigorous commitment to safety. From complex software architecture to groundbreaking scientific discovery, Fable 5 isn’t just an update—it’s a leap forward in general AI capability.

Whether you are a developer, a researcher, or a business leader, Claude Fable 5 delivers state-of-the-art performance across nearly every tested benchmark, proving that the more complex the task, the greater Fable 5’s advantage over previous generations.

Unrivalled Performance Across Key Domains

Claude Fable 5 excels where other models struggle, offering deep reasoning and autonomous execution in several critical areas:

  • Revolutionary Software Engineering: Fable 5 is transforming the development lifecycle. In real-world testing with Stripe, the model compressed months of engineering work into mere days, completing a massive codebase migration in a 50-million-line Ruby environment that would have typically required a full team two months to execute manually.
  • Advanced Knowledge Work: For high-level analytical tasks, Fable 5 is currently the gold standard. It has achieved top scores in senior-level financial reasoning, excelling in document interpretation, root-cause analysis, and complex problem-solving.
  • Next-Gen Computer Vision: Beyond simple image recognition, Fable 5 can rebuild a web application’s source code from screenshots alone and extract precise data from intricate scientific figures.
  • Enhanced Memory and Context: With the ability to stay focused across millions of tokens, Fable 5 utilizes persistent file-based memory to improve its outputs, showing a massive performance boost in complex, long-running simulations and games.

Claude Mythos 5: Empowering Science and Security

Alongside the general release, we are introducing Claude Mythos 5. While it shares the same core architecture as Fable 5, Mythos 5 is a specialized version with lifted safeguards in specific areas, reserved for a trusted group of cyber-defenders and scientific researchers via advanced research frameworks.

The impact of Mythos 5 is already being felt in the life sciences:

  • Drug Design: Internal experts reported a 10x acceleration in the protein design process, with the AI matching or exceeding skilled human operators in selecting binding sites and running bioinformatics tools.
  • Genomics & Molecular Biology: Mythos 5 has autonomously conducted genomics research across 138 species, designing a custom ML model that outperformed existing research published in leading journals.

A Balanced Approach to AI Safety

With great power comes great responsibility. To prevent the misuse of these capabilities—particularly in cybersecurity and biology—we have implemented a sophisticated system of AI classifiers. These safeguards detect potential misuse or “jailbreak” attempts in real-time.

If a query is flagged as potentially harmful, the system seamlessly falls back to Claude Opus 4.8. This ensures that users still receive a highly capable response without compromising global security. Our data shows that over 95% of sessions proceed without any fallback, meaning the vast majority of users experience the full power of Fable 5 uninterrupted.

Pricing and Availability

We believe advanced AI should be accessible. Claude Fable 5 is available now via the Claude API with a highly competitive pricing structure:

  • Input Tokens: $10 per million
  • Output Tokens: $50 per million

This represents a significant cost reduction (less than half the price of Claude Mythos Preview), making frontier-level AI viable for startups and enterprises alike. Developers can start integrating claude-fable-5 into their workflows today through the official API.

Stay tuned as we continue to refine our safeguards and expand the Trusted Access Program for biomedical and cybersecurity pioneers.

Scroll to Top